PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 33670212-0 2021 Enhanced UV Photoresponsivity of ZnO Nanorods Decorated with Ag2S/ZnS Nanoparticles by Successive Ionic Layer Adsorption and Reaction Method. Zinc Oxide 33-36 angiotensin II receptor type 1 Homo sapiens 61-65 34180924-2 2021 Herein, we developed a new signal-amplified photoelectrochemical (PEC) immunosensing method for quantitative monitoring of the target PSA based on the ion-exchange reaction for the in situ formation of ZnO/CdS/Ag2S nanohybrids triggered by the as-released silver ions (Ag+) from silver nanolabels. Zinc Oxide 202-205 angiotensin II receptor type 1 Homo sapiens 210-214 34180924-5 2021 In this regard, an ion-exchange reaction occurred between the silver ions and ZnO/CdS nanorods on the photosensitive electrode, thus producing ZnO/CdS/Ag2S nanohybrids to generate a relatively strong photocurrent. Zinc Oxide 78-81 angiotensin II receptor type 1 Homo sapiens 151-155 34180924-5 2021 In this regard, an ion-exchange reaction occurred between the silver ions and ZnO/CdS nanorods on the photosensitive electrode, thus producing ZnO/CdS/Ag2S nanohybrids to generate a relatively strong photocurrent. Zinc Oxide 143-146 angiotensin II receptor type 1 Homo sapiens 151-155 33670212-2 2021 In this work, ZnO nanorods were prepared by the hydrothermal method and then decorated with silver sulfide (Ag2S)/zinc sulfide (ZnS) via two-step successive ionic layer adsorption and reaction method. Zinc Oxide 14-17 angiotensin II receptor type 1 Homo sapiens 108-112 33295340-0 2021 Photoelectrochemical thrombin biosensor based on perylene-3,4,9,10-tetracarboxylic acid and Au co-functionalized ZnO nanorods with signal-off quenching effect of Ag@Ag2S. Zinc Oxide 113-116 angiotensin II receptor type 1 Homo sapiens 165-169 33295340-1 2021 In this work, a thrombin photoelectrochemical aptasensor was reported based on a photoanode of perylene-3,4,9,10-tetracarboxylic acid (PTCA), Au nanoparticle co-functionalized ZnO nanorods (ZnO NRs) and the "signal-off" amplification effect of Ag@Ag2S. Zinc Oxide 176-179 angiotensin II receptor type 1 Homo sapiens 247-251 30500804-0 2018 Photocatalytic performance of Ag2S/ZnO/ZnS nanocomposites with high visible light response prepared via microwave-assisted hydrothermal two-step method. Zinc Oxide 35-38 angiotensin II receptor type 1 Homo sapiens 30-34 32866723-1 2020 In this work, a signal amplification competitive-type photoelectrochemical system comprised of bismuth sulfide/bismuth oxyiodide/zinc oxide (Bi2S3/BiOI/ZnO) nano-array as platform and Ag2S-modified aptamers probe DNA (p DNA@Ag2S) as competition content for rapid and sensitive detection of OTA in microfluidic devices. Zinc Oxide 129-139 angiotensin II receptor type 1 Homo sapiens 184-188 32866723-5 2020 After immobilizing with the capture DNA (c DNA) and the sequential hybridization of p DNA@Ag2S, the photocurrent intensity reduced obviously because part photo-generated electron transformed to Ag2S rather than Bi2S3/BiOI/ZnO electrode. Zinc Oxide 222-225 angiotensin II receptor type 1 Homo sapiens 90-94 31460417-4 2019 Ternary Ag2S/NiO-ZnO nanocomposites showed excellent visible light photocatalytic property which increases further with the concentration of Ag2S. Zinc Oxide 17-20 angiotensin II receptor type 1 Homo sapiens 8-12 31460417-4 2019 Ternary Ag2S/NiO-ZnO nanocomposites showed excellent visible light photocatalytic property which increases further with the concentration of Ag2S. Zinc Oxide 17-20 angiotensin II receptor type 1 Homo sapiens 141-145 30500804-6 2018 Meanwhile, 1% Ag2S/ZnO/ZnS also showed a good degradation effect on other dyes with different structures, and its degradation efficiency did not change significantly after three cycles, showing certain stability. Zinc Oxide 19-22 angiotensin II receptor type 1 Homo sapiens 14-18 30500804-3 2018 At the same time, due to the introduction of narrow band gap Ag2S, the synthesized composite can effectively increase the visible optical absorption of ZnO/ZnS composites. Zinc Oxide 152-155 angiotensin II receptor type 1 Homo sapiens 61-65 30500804-4 2018 Among them, 1% Ag2S/ZnO/ZnS showed a mixed structure of nano-line and nano-particle, of which BET value increased significantly, and the morphology was more excellent. Zinc Oxide 20-23 angiotensin II receptor type 1 Homo sapiens 15-19 29022694-5 2017 The small weight ratio of Ag2S QDs to ZnO@C at 1:180 shows the best performance in lithium storage. Zinc Oxide 38-41 angiotensin II receptor type 1 Homo sapiens 26-30 29022694-0 2017 Enhancing Distorted Metal-Organic Framework-Derived ZnO as Anode Material for Lithium Storage by the Addition of Ag2S Quantum Dots. Zinc Oxide 52-55 angiotensin II receptor type 1 Homo sapiens 113-117 29022694-1 2017 The lithium storage properties of the distorted metal-organic framework-derived nanosized ZnO@C are significantly improved by the introduction of Ag2S quantum dots (QDs) during the processing of the material. Zinc Oxide 90-93 angiotensin II receptor type 1 Homo sapiens 146-150 29022694-7 2017 At low current densities (200 mA g-1), treatment of ZnO@C with Ag2S QDs results in a 38% increase in the specific capacity. Zinc Oxide 52-55 angiotensin II receptor type 1 Homo sapiens 63-67 27922086-1 2016 In this work, a new photoelectrochemical biosensor based on Ag2S nanoparticles (NPs) modified macroporous ZnO inverse opals structure (IOs) was developed for sensitive and rapid detection of alpha fetal protein (AFP). Zinc Oxide 106-109 angiotensin II receptor type 1 Homo sapiens 60-64 27922086-2 2016 Small size and uniformly dispersed Ag2S NPs were prepared using the Successive Ionic Layer Adsorption And Reaction (SILAR) method, which were adsorbed on ZnO IOs surface and frame work as matrix for immobilization of AFP. Zinc Oxide 154-157 angiotensin II receptor type 1 Homo sapiens 35-39 27922086-3 2016 The composite structure of ZnO/Ag2S expanded the scope of light absorption to long wavelength, which can make full use of the light energy. Zinc Oxide 27-30 angiotensin II receptor type 1 Homo sapiens 31-35 27142998-0 2016 Enhanced field emission properties of ZnO-Ag2S core-shell heterojunction nanowires. Zinc Oxide 38-41 angiotensin II receptor type 1 Homo sapiens 42-46 27142998-2 2016 By a simple and facile successive ionic layer adsorption and reaction (SILAR) approach, Ag2S QDs were uniformly and densely packed on ZnO nanowires (NWs) to form ZnO-Ag2S core-shell heterojunction structures. Zinc Oxide 162-165 angiotensin II receptor type 1 Homo sapiens 166-170 27142998-3 2016 The FE properties of ZnO NWAs were effectively tuned by controlling the amount of Ag2S QDs. Zinc Oxide 21-24 angiotensin II receptor type 1 Homo sapiens 82-86 27142998-1 2016 A simple approach to Ag2S quantum dot (QD) modification was used to tune the field emission (FE) properties of ZnO nanowire arrays (NWAs). Zinc Oxide 111-114 angiotensin II receptor type 1 Homo sapiens 21-25 27142998-2 2016 By a simple and facile successive ionic layer adsorption and reaction (SILAR) approach, Ag2S QDs were uniformly and densely packed on ZnO nanowires (NWs) to form ZnO-Ag2S core-shell heterojunction structures. Zinc Oxide 134-137 angiotensin II receptor type 1 Homo sapiens 88-92 27142998-2 2016 By a simple and facile successive ionic layer adsorption and reaction (SILAR) approach, Ag2S QDs were uniformly and densely packed on ZnO nanowires (NWs) to form ZnO-Ag2S core-shell heterojunction structures. Zinc Oxide 162-165 angiotensin II receptor type 1 Homo sapiens 88-92 26815888-0 2016 Enhanced visible light photocatalytic performance of ZnO nanowires integrated with CdS and Ag2S. Zinc Oxide 53-56 angiotensin II receptor type 1 Homo sapiens 91-95 26815888-2 2016 The ZnO nanowires, with a diameter of ~ 100 nm and a length of ~ 1 mum, were modified by coating CdS and Ag2S. Zinc Oxide 4-7 angiotensin II receptor type 1 Homo sapiens 105-109 26815888-5 2016 The photocatalytic activity of the ZnO-CdS-Ag2S ternary nanostructures was investigated using the degradation of methyl orange (MO) in an aqueous solution under visible light. Zinc Oxide 35-38 angiotensin II receptor type 1 Homo sapiens 43-47 26815888-6 2016 The ZnO-CdS-Ag2S ternary nanostructures were found to be more efficient than ZnO nanowires, ZnO-CdS nanowires, and ZnO-Ag2S nanowires. Zinc Oxide 4-7 angiotensin II receptor type 1 Homo sapiens 12-16 26815888-6 2016 The ZnO-CdS-Ag2S ternary nanostructures were found to be more efficient than ZnO nanowires, ZnO-CdS nanowires, and ZnO-Ag2S nanowires. Zinc Oxide 4-7 angiotensin II receptor type 1 Homo sapiens 119-123 26815888-6 2016 The ZnO-CdS-Ag2S ternary nanostructures were found to be more efficient than ZnO nanowires, ZnO-CdS nanowires, and ZnO-Ag2S nanowires. Zinc Oxide 77-80 angiotensin II receptor type 1 Homo sapiens 12-16 26815888-6 2016 The ZnO-CdS-Ag2S ternary nanostructures were found to be more efficient than ZnO nanowires, ZnO-CdS nanowires, and ZnO-Ag2S nanowires. Zinc Oxide 77-80 angiotensin II receptor type 1 Homo sapiens 12-16 26815888-6 2016 The ZnO-CdS-Ag2S ternary nanostructures were found to be more efficient than ZnO nanowires, ZnO-CdS nanowires, and ZnO-Ag2S nanowires. Zinc Oxide 77-80 angiotensin II receptor type 1 Homo sapiens 12-16 26815888-7 2016 There is 7.68 times more photocatalytic activity for MO degradation in terms of the rate constant for ZnO-CdS-Ag2S 15-cycle ternary nanostructure compared to the as-grown ZnO. Zinc Oxide 102-105 angiotensin II receptor type 1 Homo sapiens 110-114 26815888-8 2016 Furthermore, the effect of the amount of Ag2S and CdS on the ZnO surface on the photocatalytic activity was analyzed. Zinc Oxide 61-64 angiotensin II receptor type 1 Homo sapiens 41-45 26815888-9 2016 The superior photo-absorption properties and photocatalytic performance of the ZnO-CdS-Ag2S ternary nanostructures can be ascribed to the heterostructure, which enhanced the separation of the photo-induced electron-hole pairs. Zinc Oxide 79-82 angiotensin II receptor type 1 Homo sapiens 87-91 26815888-10 2016 In addition, visible light could be absorbed by ZnO-CdS-Ag2S ternary nanostructures rather than by ZnO. Zinc Oxide 48-51 angiotensin II receptor type 1 Homo sapiens 56-60 25226166-3 2014 Morphology of the sample was studied by scanning electron microscopy and it was observed that ZnO nanoplates were covered with ZnS and Ag2S nanoparticles. Zinc Oxide 94-97 angiotensin II receptor type 1 Homo sapiens 135-139 25907247-0 2015 ZnO@Ag2S core-shell nanowire arrays for environmentally friendly solid-state quantum dot-sensitized solar cells with panchromatic light capture and enhanced electron collection. Zinc Oxide 0-3 angiotensin II receptor type 1 Homo sapiens 4-8 25907247-3 2015 Ag2S quantum dots (QDs) were directly grown on the ZnO nanowires by the successive ionic layer adsorption and reaction (SILAR) method to obtain the core-shell nanostructure. Zinc Oxide 51-54 angiotensin II receptor type 1 Homo sapiens 0-4 25144692-0 2014 Band gap engineering of ZnO using core/shell morphology with environmentally benign Ag2S sensitizer for efficient light harvesting and enhanced visible-light photocatalysis. Zinc Oxide 24-27 angiotensin II receptor type 1 Homo sapiens 84-88 25144692-3 2014 We engineered the band gap of ZnO nanorods by introducing the core/shell geometry with Ag2S sensitizer as the shell. Zinc Oxide 30-33 angiotensin II receptor type 1 Homo sapiens 87-91 25144692-5 2014 To unveil the superiority of Ag2S as a sensitizer in engineering the band gap of ZnO in comparison to the Cd-based sensitizers, we also designed ZnO/CdS core/shell nanostructures having the same shell thickness. Zinc Oxide 81-84 angiotensin II receptor type 1 Homo sapiens 29-33 25144692-7 2014 The results imply that the ZnO/Ag2S core/shell nanostructures reveal 40- and 2-fold enhancement in degradation constant in comparison to the pure ZnO and ZnO/CdS core/shell nanostructures, respectively. Zinc Oxide 27-30 angiotensin II receptor type 1 Homo sapiens 31-35 25144692-7 2014 The results imply that the ZnO/Ag2S core/shell nanostructures reveal 40- and 2-fold enhancement in degradation constant in comparison to the pure ZnO and ZnO/CdS core/shell nanostructures, respectively. Zinc Oxide 146-149 angiotensin II receptor type 1 Homo sapiens 31-35 25144692-7 2014 The results imply that the ZnO/Ag2S core/shell nanostructures reveal 40- and 2-fold enhancement in degradation constant in comparison to the pure ZnO and ZnO/CdS core/shell nanostructures, respectively. Zinc Oxide 146-149 angiotensin II receptor type 1 Homo sapiens 31-35 25144692-8 2014 This high efficiency is elucidated in terms of (i) efficient light harvesting owing to the incorporation of Ag2S and (ii) smaller conduction band offset between ZnO and Ag2S, promoting more efficient charge separation at the core/shell interface. Zinc Oxide 161-164 angiotensin II receptor type 1 Homo sapiens 108-112 25144692-9 2014 A credible photodegradation mechanism for the MB dye deploying ZnO/Ag2S core/shell nanostructures is proposed from the analysis of involved active species such as hydroxyl radicals (OH( )), electrons (e(-)(CB)), holes (h(+)(VB)), and superoxide radical anions (O2( -)) in the photodegradation process utilizing various active species scavengers and EPR spectroscopy. Zinc Oxide 63-66 angiotensin II receptor type 1 Homo sapiens 67-71 23318775-3 2013 Ag(2)S-ZnO is found to be more efficient than commercial ZnO, prepared ZnO and TiO(2)-P25 at pH 9 for the mineralization of Acid Black 1. Zinc Oxide 7-10 angiotensin II receptor type 1 Homo sapiens 0-6 23318775-0 2013 Ag2S-ZnO--an efficient photocatalyst for the mineralization of Acid Black 1 with UV light. Zinc Oxide 5-8 angiotensin II receptor type 1 Homo sapiens 0-4 23318775-1 2013 The Ag(2)S loaded ZnO (Ag(2)S-ZnO) was successfully synthesized by precipitation of zinc oxalate and Ag(2)S and calcination of the mixed precipitate at 400 C for 12 h. The catalyst was characterized by X-ray diffraction (XRD), scanning electron microscope (SEM) images, energy dispersive spectra (EDS), diffuse reflectance spectra (DRS) photoluminescence spectra (PL) and BET surface area measurements. Zinc Oxide 18-21 angiotensin II receptor type 1 Homo sapiens 4-10 23318775-1 2013 The Ag(2)S loaded ZnO (Ag(2)S-ZnO) was successfully synthesized by precipitation of zinc oxalate and Ag(2)S and calcination of the mixed precipitate at 400 C for 12 h. The catalyst was characterized by X-ray diffraction (XRD), scanning electron microscope (SEM) images, energy dispersive spectra (EDS), diffuse reflectance spectra (DRS) photoluminescence spectra (PL) and BET surface area measurements. Zinc Oxide 18-21 angiotensin II receptor type 1 Homo sapiens 23-29 23318775-1 2013 The Ag(2)S loaded ZnO (Ag(2)S-ZnO) was successfully synthesized by precipitation of zinc oxalate and Ag(2)S and calcination of the mixed precipitate at 400 C for 12 h. The catalyst was characterized by X-ray diffraction (XRD), scanning electron microscope (SEM) images, energy dispersive spectra (EDS), diffuse reflectance spectra (DRS) photoluminescence spectra (PL) and BET surface area measurements. Zinc Oxide 18-21 angiotensin II receptor type 1 Homo sapiens 23-29 23318775-1 2013 The Ag(2)S loaded ZnO (Ag(2)S-ZnO) was successfully synthesized by precipitation of zinc oxalate and Ag(2)S and calcination of the mixed precipitate at 400 C for 12 h. The catalyst was characterized by X-ray diffraction (XRD), scanning electron microscope (SEM) images, energy dispersive spectra (EDS), diffuse reflectance spectra (DRS) photoluminescence spectra (PL) and BET surface area measurements. Zinc Oxide 30-33 angiotensin II receptor type 1 Homo sapiens 4-10 23318775-1 2013 The Ag(2)S loaded ZnO (Ag(2)S-ZnO) was successfully synthesized by precipitation of zinc oxalate and Ag(2)S and calcination of the mixed precipitate at 400 C for 12 h. The catalyst was characterized by X-ray diffraction (XRD), scanning electron microscope (SEM) images, energy dispersive spectra (EDS), diffuse reflectance spectra (DRS) photoluminescence spectra (PL) and BET surface area measurements. Zinc Oxide 30-33 angiotensin II receptor type 1 Homo sapiens 23-29 23318775-1 2013 The Ag(2)S loaded ZnO (Ag(2)S-ZnO) was successfully synthesized by precipitation of zinc oxalate and Ag(2)S and calcination of the mixed precipitate at 400 C for 12 h. The catalyst was characterized by X-ray diffraction (XRD), scanning electron microscope (SEM) images, energy dispersive spectra (EDS), diffuse reflectance spectra (DRS) photoluminescence spectra (PL) and BET surface area measurements. Zinc Oxide 30-33 angiotensin II receptor type 1 Homo sapiens 23-29 23318775-2 2013 The photocatalytic activity of Ag(2)S-ZnO was investigated for the degradation of Acid Black (AB 1) in aqueous solution using UV light. Zinc Oxide 38-41 angiotensin II receptor type 1 Homo sapiens 31-37 23318775-3 2013 Ag(2)S-ZnO is found to be more efficient than commercial ZnO, prepared ZnO and TiO(2)-P25 at pH 9 for the mineralization of Acid Black 1. Zinc Oxide 57-60 angiotensin II receptor type 1 Homo sapiens 0-6 23318775-3 2013 Ag(2)S-ZnO is found to be more efficient than commercial ZnO, prepared ZnO and TiO(2)-P25 at pH 9 for the mineralization of Acid Black 1. Zinc Oxide 57-60 angiotensin II receptor type 1 Homo sapiens 0-6 23318775-5 2013 Mechanism of degradation by Ag(2)S-ZnO is proposed. Zinc Oxide 35-38 angiotensin II receptor type 1 Homo sapiens 28-34 23233308-0 2013 Environmentally benign and efficient Ag2S-ZnO nanowires as photoanodes for solar cells: comparison with CdS-ZnO nanowires. Zinc Oxide 42-45 angiotensin II receptor type 1 Homo sapiens 37-41 23233308-1 2013 In this work, we develop a low-temperature, facile solution reaction route for the fabrication of quantum-dot-sensitized solar cells (QDSSCs) containing Ag(2)S-ZnO nanowires (NWs), simultaneously ensuring low manufacturing costs and environmental safety. Zinc Oxide 160-163 angiotensin II receptor type 1 Homo sapiens 153-159 23233308-4 2013 Compared to CdS-ZnO QDSSCs, Ag(2)S-ZnO QDSSCs exhibit a considerably higher short-circuit current density (J(sc)) and a strongly enhanced light-harvesting efficiency, but lower open-circuit voltages (V(oc)), resulting in almost the same power-conversion efficiency of 1.2 %. Zinc Oxide 16-19 angiotensin II receptor type 1 Homo sapiens 28-34 21777458-0 2011 Improved conversion efficiency of Ag2S quantum dot-sensitized solar cells based on TiO2 nanotubes with a ZnO recombination barrier layer. Zinc Oxide 105-108 angiotensin II receptor type 1 Homo sapiens 34-38 21777458-1 2011 We improve the conversion efficiency of Ag2S quantum dot (QD)-sensitized TiO2 nanotube-array electrodes by chemically depositing ZnO recombination barrier layer on plain TiO2 nanotube-array electrodes. Zinc Oxide 129-132 angiotensin II receptor type 1 Homo sapiens 40-44 21777458-4 2011 In addition, as compared to the Ag2S QD-sensitized TiO2 nanotube-array electrode without the ZnO layers, the conversion efficiency of the electrode with the ZnO layers increases significantly due to the formation of efficient recombination layer between the TiO2 nanotube array and electrolyte. Zinc Oxide 157-160 angiotensin II receptor type 1 Homo sapiens 32-36 23233308-4 2013 Compared to CdS-ZnO QDSSCs, Ag(2)S-ZnO QDSSCs exhibit a considerably higher short-circuit current density (J(sc)) and a strongly enhanced light-harvesting efficiency, but lower open-circuit voltages (V(oc)), resulting in almost the same power-conversion efficiency of 1.2 %. Zinc Oxide 35-38 angiotensin II receptor type 1 Homo sapiens 28-34